EUVIMEDОткрийте EUVIMED
Randomisierte kontrollierte StudieOpen access

Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial

Kontinuierliches Glukosemonitoring mit geriatrischen Prinzipien bei älteren Erwachsenen mit Typ-1-Diabetes und Hypoglykämie: randomisierte kontrollierte Studie

Medha N Munshi iD, Christine Slyne, Atif Adam iD, Colin Conery, Adeolu Oladunjoye, Simon Neuwahl iD, David Wypij, Elena Toschi iD

Diabetes Care · 2024-09-26

DOI: 10.2337/dc24-1069 ↗

Auf einen Blick

Bei älteren Erwachsenen mit Typ-1-Diabetes und Hypoglykämie senkte CGM mit geriatrischen Prinzipien die Zeit mit Glukose <70 mg/dL gegenüber der Regelversorgung. Die glykämische Kontrolle verschlechterte sich nicht.

Fragestellung

Verbessert CGM kombiniert mit geriatrischen Prinzipien bei älteren Erwachsenen mit Typ-1-Diabetes und Hypoglykämie die Hypoglykämie gegenüber üblicher Versorgung?

Methode

Randomisierte kontrollierte Studie bei Erwachsenen ≥65 Jahre mit Typ-1-Diabetes und Hypoglykämie; Intervention über 6 Monate mit CGM plus geriatrischen Prinzipien; Kontrolle: übliche Versorgung.

Ergebnisse

131 Teilnehmende. Medianer Unterschied der Veränderung der Hypoglykämie von Baseline bis 6 Monate: −2.3 % (95 %-KI −3.7 bis −1.3; P < 0.001). HbA1c: 7.5 % vs. 7.3 %.

Schlussfolgerung der Autor:innen

Bei älteren Erwachsenen mit Typ-1-Diabetes und hohem Hypoglykämierisiko konnte CGM mit geriatrischen Prinzipien Hypoglykämie senken, ohne die glykämische Kontrolle zu verschlechtern; das Vorgehen war kosteneffektiv.

Kernaussagen

  • Hypoglykämie nahm unter der Intervention stärker ab als unter üblicher Versorgung.
  • Kein Unterschied beim HbA1c zwischen den Gruppen.
  • Die Intervention war kosteneffektiv.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in Diabetes Care, published online on 2024-09-26. Written by Medha N Munshi and 7 co-authors. Institution: Joslin Diabetes Center, Clinical Research, Boston, MA. Major MEDLINE topics: Blood Glucose, Continuous Glucose Monitoring, Diabetes Mellitus, Type 1, Hypoglycemia. Cited 20 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

Auf einen BlickРезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

OBJECTIVE Continuous glucose monitoring (CGM) use in older adults with type 1 diabetes (T1D) has shown benefits. However, the impact of CGM use, coupled with simplified treatment regimens and personalized glycemic goals that are better suited for older patients with multiple comorbidities and hypoglycemia, is not known. RESEARCH DESIGN AND METHODS Older adults (≥65 years) with T1D with hypoglycemia (two or more episodes of hypoglycemia [blood glucose <70 mg/dL for ≥20 min over 2 weeks]) who were CGM naïve or CGM users were randomized to intervention and control groups. The intervention consisted of the combined use of CGM with geriatric principles (i.e., adjusting goals based on overall health, and simplification of regimens based on CGM patterns and clinical characteristics) over 6 months. The control group received usual care by their endocrinologist. The primary end point was change in time when blood glucose was <70 mg/dL from baseline to 6 months. Cost-effectiveness was calculated using a health care sector perspective. RESULTS We randomized 131 participants (aged 71 ± 5 years; 21% ≥75 years old) to the intervention (n = 68; CGM users = 33) or the control (n = 63; CGM users = 40) group. The median change in hypoglycemia from baseline to 6 months was −2·6% in the intervention group and −0.3% in the control group (median difference, −2.3% [95% CI −3.7%, −1.3%]; P < 0.001). This improvement was seen in both CGM naïve (−2.8%; 95% CI −5.6%, −0.8%) and CGM users (−1.2%; 95% CI −2.7%, −0.1%). The HbA1c did not differ between the groups (7.5% vs 7.3%). The intervention was cost-effective (incremental cost-effectiveness ratio $71,623 per quality adjusted life-year). CONCLUSIONS In older adults with T1D and high risk of hypoglycemia, CGM use enhanced by geriatric principles can lower hypoglycemia without worsening glycemic control in a cost-effective fashion.

Subjects

MeSH terms (MEDLINE)

Blood GlucoseContinuous Glucose MonitoringDiabetes Mellitus, Type 1HypoglycemiaAgedAged, 80 and overFemaleHumansMaleHypoglycemic Agents

Substances

Blood GlucoseHypoglycemic Agents

Authors and institutions

  • Joslin Diabetes Center, Clinical Research, Boston, MA.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
  • Harvard Medical School, Boston, MA.
  • Boston Children's Hospital, Boston, MA.
  • Research Triangle Institute, Research Triangle Park, NC.
  • Harvard T.H. Chan School of Public Health, Boston, MA.

ORCID profiles: Medha N Munshi, Atif Adam, Simon Neuwahl, Elena Toschi

Funding

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Munshi, M. N., Slyne, C., Adam, A., Conery, C., Oladunjoye, A., Neuwahl, S., Wypij, D., & Toschi, E. (2024). Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial. Diabetes Care. https://doi.org/10.2337/dc24-1069

Vancouver

Munshi MN, Slyne C, Adam A, Conery C, Oladunjoye A, Neuwahl S, et al. Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial. Diabetes Care. 2024. doi:10.2337/dc24-1069

BibTeX
@article{Munshi2024,
  author = {Munshi, Medha N and Slyne, Christine and Adam, Atif and Conery, Colin and Oladunjoye, Adeolu and Neuwahl, Simon and Wypij, David and Toschi, Elena},
  title = {Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial},
  journal = {Diabetes Care},
  year = {2024},
  doi = {10.2337/dc24-1069}
}
Start for free →